These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Interferon alfa-2a in the treatment of Behçet's disease. Azizlerli G; Sarica R; Köse A; Ovül C; Kavala M; Kayabali M; Erkan F; Kural Z Dermatology; 1996; 192(3):239-41. PubMed ID: 8726638 [TBL] [Abstract][Full Text] [Related]
12. [Interferon and Behcet's disease. Therapeutic exception or loss of chance?]. Wechsler B Rev Med Interne; 2000 Sep; 21(9):745-6. PubMed ID: 11039169 [No Abstract] [Full Text] [Related]
13. Interferon therapy for Behçet's disease. Alpsoy E; Yilmaz E; Başaran E J Am Acad Dermatol; 1994 Oct; 31(4):617-9. PubMed ID: 8089288 [TBL] [Abstract][Full Text] [Related]
14. [Behçet's syndrome: treatment with recombinant interferon gamma]. Kirch W; Dührsen U Dtsch Med Wochenschr; 1990 Mar; 115(9):357. PubMed ID: 2106427 [No Abstract] [Full Text] [Related]
15. [Behçet's disease: therapy with recombinant interferon gamma]. Fierlbeck G Dtsch Med Wochenschr; 1989 Nov; 114(45):1769. PubMed ID: 2509188 [No Abstract] [Full Text] [Related]
16. Treatment of Adamantiades-Behçet disease with systemic interferon alfa. Zouboulis CC; Orfanos CE Arch Dermatol; 1998 Aug; 134(8):1010-6. PubMed ID: 9722733 [TBL] [Abstract][Full Text] [Related]